I was first drawn to medicine because I wanted to help people. I chose hematology and oncology because they are rapidly evolving fields—through their advances, I can treat people using the newest therapies. More importantly, I can care for people by forging meaningful relationships with them.
I treat each patient as a partner, and together, we work toward a common goal. Communication with my patients and their caregivers is essential to providing the best care. I also prioritize providing my patients with access to clinical trials.
At Perlmutter Cancer Center, my colleagues and I approach cancer treatment as a collaboration between specialties. We offer patients the most current clinical trials and we strive to provide as much support as possible for patients and families during such a difficult time.
My clinical and research interest is gastrointestinal cancers, with a focus on liver and biliary cancer, pancreatic cancer, and gastric cancer. Currently, I am studying whether radiation therapy in combination with immunotherapy is an effective treatment for pancreatic cancer.
Conditions and Treatments
- gastrointestinal cancer
- colon cancer
- rectal cancer
- pancreatic cancer
- esophageal cancer
- stomach cancer
- anal cancer
- gallbladder cancer
- biliary cancer
- liver cancer
- colorectal cancer
- abdominal tumor
This provider accepts the following insurance plans.
A Phase 1 Parallel Open-Label Study of the Safety and Tolerability Pharmacokinetics and Antileukemic Activity of ASTX660 as a Single Agent and in Combination with ASTX727 in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
A Phase 2 Randomized Double-blind Study of Glutaminase Inhibitor Telaglenastat with Pembrolizumab and Chemotherapy vs Placebo with Pembrolizumab and Chemotherapy in Front-line Metastatic KEAP1/NRF2- mutated Nonsquamous Non-Small Cell Lung (NSCLC)
Results of a Survey of the National Psoriasis Foundation Medical Board on the Management of Ear Psoriasis
Journal of psoriasis & psoriatic arthritis. 2020 Jan 01; 5(1):28-31
World journal of clinical oncology. 2019 Mar 24; 10(3):149-160
Chinese clinical oncology. 2018 Oct ; 7(5):50